{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:04:11Z","timestamp":1790013851864,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2024YFA1210100"],"award-info":[{"award-number":["2024YFA1210100"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11095-026-04134-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:40:48Z","timestamp":1782852048000},"page":"2795-2809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sustained Intra-Articular Delivery of Triple Therapeutics Using a Phase-Transition Phospholipid-Based Gel for Effective Treatment of Gouty Arthritis"],"prefix":"10.1007","volume":"43","author":[{"given":"Sirui","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9866-9911","authenticated-orcid":false,"given":"Tao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"4134_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet. 2021;397:1843\u201355.","journal-title":"Lancet"},{"key":"4134_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.4103\/japtr.japtr_144_23","volume":"14","author":"N Parisa","year":"2023","unstructured":"Parisa N, Kamaluddin MT, Saleh MI, Sinaga E. The inflammation process of gout arthritis and its treatment. J Adv Pharm Technol Res. 2023;14:166\u201370.","journal-title":"J Adv Pharm Technol Res"},{"key":"4134_CR3","doi-asserted-by":"publisher","first-page":"1137822","DOI":"10.3389\/fimmu.2023.1137822","volume":"14","author":"Y-R Liu","year":"2023","unstructured":"Liu Y-R, Wang J-Q, Li J. Role of NLRP3 in the pathogenesis and treatment of gout arthritis. Front Immunol. 2023;14:1137822, 1137822.","journal-title":"Front Immunol"},{"key":"4134_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/imr.12833","volume":"294","author":"G Cab\u0103u","year":"2020","unstructured":"Cab\u0103u G, Cri\u0219an TO, Kl\u00fcck V, Popp RA, Joosten LAB. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia. Immunol Rev. 2020;294:92\u2013105.","journal-title":"Immunol Rev"},{"issue":"1","key":"4134_CR5","doi-asserted-by":"publisher","first-page":"39884","DOI":"10.1038\/srep39884","volume":"7","author":"TT Braga","year":"2017","unstructured":"Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep. 2017;7:39884, 39884.","journal-title":"Sci Rep"},{"key":"4134_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F. Inflammation in gout: mechanisms and therapeutic targets. Nat Rev Rheumatol. 2017;13:639\u201347.","journal-title":"Nat Rev Rheumatol"},{"key":"4134_CR7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.4049\/jimmunol.1001284","volume":"186","author":"B Paz\u00e1r","year":"2011","unstructured":"Paz\u00e1r B, Ea H-K, Narayan S, Kolly L, Bagnoud N, Chobaz V, et al. Basic calcium phosphate crystals induce monocyte\/macrophage IL-1\u03b2 secretion through the NLRP3 inflammasome in vitro. J Immunol. 2011;186:2495\u2013502.","journal-title":"J Immunol"},{"key":"4134_CR8","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","volume":"50","author":"A Mantovani","year":"2019","unstructured":"Mantovani A, Dinarello CA, Molgora M, Garlanda C. Interleukin-1 and related cytokines in the regulation of inflammation and immunity. Immunity. 2019;50:778\u201395.","journal-title":"Immunity"},{"key":"4134_CR9","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1093\/rheumatology\/keq037","volume":"49","author":"E Krishnan","year":"2010","unstructured":"Krishnan E. Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford). 2010;49:1229\u201338.","journal-title":"Rheumatology (Oxford)"},{"key":"4134_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s41565-024-01715-0","volume":"19","author":"J Xu","year":"2024","unstructured":"Xu J, Wu M, Yang J, Zhao D, He D, Liu Y, et al. Multimodal smart systems reprogramme macrophages and remove urate to treat gouty arthritis. Nat Nanotechnol. 2024;19:1544\u201357.","journal-title":"Nat Nanotechnol"},{"key":"4134_CR11","doi-asserted-by":"publisher","first-page":"1469879","DOI":"10.3389\/fmed.2025.1469879","volume":"12","author":"C Zheng","year":"2025","unstructured":"Zheng C, Tong Q, Zhang Z, Lin C, Wang Z, Kang D, et al. The efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout. Front Med. 2025;12:1469879, 1469879.","journal-title":"Front Med"},{"key":"4134_CR12","doi-asserted-by":"publisher","first-page":"1438405","DOI":"10.3389\/fendo.2024.1438405","volume":"15","author":"X Xu","year":"2024","unstructured":"Xu X, Yu D, Wang Y, Jiang X, Lu F, Liu S. Investigating the mechanisms of resveratrol in the treatment of gouty arthritis through the integration of network pharmacology and metabolics. Front Endocrinol (Lausanne). 2024;15:1438405.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4134_CR13","first-page":"60","volume":"92","author":"MA Gromova","year":"2020","unstructured":"Gromova MA, Tsurko VV, Kislyak OA. Malysheva NV [Evaluation of a 12-week allopurinol-lowering therapy in combination with the non-steroidal anti-inflammatory drug meloxicam in patients with gout]. Ter Arkh. 2020;92:60\u20138.","journal-title":"Ter Arkh"},{"key":"4134_CR14","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1080\/10717544.2022.2144545","volume":"29","author":"Z Sun","year":"2022","unstructured":"Sun Z, Gu X, Hao T, Liu J, Gao R, Li Y, et al. Intra-articular injection PLGA blends sustained-release microspheres loaded with meloxicam: preparation, optimization, evaluation in vitro and in vivo. Drug Deliv. 2022;29:3317\u201327.","journal-title":"Drug Deliv"},{"key":"4134_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41584-023-01006-3","volume":"19","author":"N Schlesinger","year":"2023","unstructured":"Schlesinger N, P\u00e9rez-Ruiz F, Liot\u00e9 F. Mechanisms and rationale for uricase use in patients with gout. Nat Rev Rheumatol. 2023;19:640\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"4134_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/07388551.2024.2424362","volume":"45","author":"CE Costa","year":"2025","unstructured":"Costa CE, Roman\u00ed A, Domingues L. Overview of resveratrol properties, applications, and advances in microbial precision fermentation. Crit Rev Biotechnol. 2025;45:788\u2013804.","journal-title":"Crit Rev Biotechnol"},{"key":"4134_CR17","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0244","author":"D Setyawan","year":"2019","unstructured":"Setyawan D, Dewi MY, Isadiartuti D. Ternary solid dispersion to improve solubility and dissolution of meloxicam. J Basic Clin Physiol Pharmacol. 2019. https:\/\/doi.org\/10.1515\/jbcpp-2019-0244.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"4134_CR18","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1021\/acs.biomac.2c01388","volume":"24","author":"L Tran","year":"2023","unstructured":"Tran L, Das S, Zhao L, Finn MG, Gaucher EA. Oral delivery of nanoparticles carrying ancestral uricase enzyme protects against hyperuricemia in knockout mice. Biomacromolecules. 2023;24:2003\u20138.","journal-title":"Biomacromolecules"},{"key":"4134_CR19","doi-asserted-by":"publisher","first-page":"111073","DOI":"10.1016\/j.foodres.2022.111073","volume":"155","author":"K Liu","year":"2022","unstructured":"Liu K, Chen Y-Y, Pan L-H, Li Q-M, Luo J-P, Zha X-Q. Co-encapsulation systems for delivery of bioactive ingredients. Food Res Int. 2022;155:111073, 111073.","journal-title":"Food Res Int"},{"key":"4134_CR20","doi-asserted-by":"publisher","first-page":"122416","DOI":"10.1016\/j.ijpharm.2022.122416","volume":"630","author":"D Ding","year":"2023","unstructured":"Ding D, Liu C, Zhang Y, Xu W, Cai Y, Zhong T, et al. Mechanistic insights of different release behaviors dominated by drug physicochemical properties in polyisobutylene pressure sensitive adhesive. Int J Pharm. 2023;630:122416, 122416.","journal-title":"Int J Pharm"},{"key":"4134_CR21","doi-asserted-by":"publisher","first-page":"1398730","DOI":"10.3389\/fbioe.2024.1398730","volume":"12","author":"H Mao","year":"2024","unstructured":"Mao H, Zhou J, Yan L, Zhang S, Yu D-G. Hybrid films loaded with 5-fluorouracil and Reglan for synergistic treatment of colon cancer via asynchronous dual-drug delivery. Front Bioeng Biotechnol. 2024;12:1398730, 1398730.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"4134_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"X Li","year":"2024","unstructured":"Li X, Peng X, Zoulikha M, Boafo GF, Magar KT, Ju Y, et al. Multifunctional nanoparticle-mediated combining therapy for human diseases. Signal Transduct Target Ther. 2024;9:1, 1.","journal-title":"Signal Transduct Target Ther"},{"key":"4134_CR23","doi-asserted-by":"publisher","first-page":"1389922","DOI":"10.3389\/fphar.2024.1389922","volume":"15","author":"L Sun","year":"2024","unstructured":"Sun L, Li Z, Lan J, Wu Y, Zhang T, Ding Y. Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy. Front Pharmacol. 2024;15:1389922, 1389922.","journal-title":"Front Pharmacol"},{"issue":"8","key":"4134_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/gels10080497","volume":"10","author":"AI Visan","year":"2024","unstructured":"Visan AI, Negut I. Development and applications of PLGA hydrogels for sustained delivery of therapeutic agents. Gels. 2024;10:497, 497.","journal-title":"Gels"},{"key":"4134_CR25","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jconrel.2022.11.018","volume":"352","author":"P Song","year":"2022","unstructured":"Song P, Cui Z, Hu L. Applications and prospects of intra-articular drug delivery system in arthritis therapeutics. J Control Release. 2022;352:946\u201360.","journal-title":"J Control Release"},{"key":"4134_CR26","doi-asserted-by":"publisher","first-page":"119559","DOI":"10.1016\/j.carbpol.2022.119559","volume":"291","author":"S Kim","year":"2022","unstructured":"Kim S, Lee HJ, Jeong B. Hyaluronic acid-g-PPG and PEG-PPG-PEG hybrid thermogel for prolonged gel stability and sustained drug release. Carbohydr Polym. 2022;291:119559, 119559.","journal-title":"Carbohydr Polym"},{"key":"4134_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijpharm.2017.06.013","volume":"528","author":"T Chen","year":"2017","unstructured":"Chen T, Gong T, Zhao T, Liu X, Fu Y, Zhang Z, et al. Paclitaxel loaded phospholipid-based gel as a drug delivery system for local treatment of glioma. Int J Pharm. 2017;528:127\u201332.","journal-title":"Int J Pharm"},{"key":"4134_CR28","doi-asserted-by":"publisher","first-page":"123897","DOI":"10.1016\/j.ijpharm.2024.123897","volume":"653","author":"M Wu","year":"2024","unstructured":"Wu M, Zhang W, Zhou X, Wang Z, Li S, Guo C, et al. An in situ forming gel co-loaded with pirarubicin and celecoxib inhibits postoperative recurrence and metastasis of breast cancer. Int J Pharm. 2024;653:123897.","journal-title":"Int J Pharm"},{"key":"4134_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2016.03.036","volume":"230","author":"M Wang","year":"2016","unstructured":"Wang M, Shan F, Zou Y, Sun X, Zhang Z-R, Fu Y, et al. Pharmacokinetic and pharmacodynamic study of a phospholipid-based phase separation gel for once a month administration of octreotide. J Control Release. 2016;230:45\u201356.","journal-title":"J Control Release"},{"key":"4134_CR30","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.xphs.2015.12.002","volume":"105","author":"N Xiang","year":"2016","unstructured":"Xiang N, Zhou X, He X, Zhang Y, Zhang J, Zhang Z-R, et al. An injectable gel platform for the prolonged therapeutic effect of pitavastatin in the management of hyperlipidemia. J Pharm Sci. 2016;105:1148\u201355.","journal-title":"J Pharm Sci"},{"key":"4134_CR31","doi-asserted-by":"crossref","unstructured":"Tao R, Liu L, Xiong Y, Zhang Q, Lv X, He L, et al. Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole. Drug Deliv Transl Res. 2023;13:2819\u201333.","DOI":"10.1007\/s13346-023-01349-0"},{"key":"4134_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3109\/03639045.2014.884129","volume":"41","author":"G Shan-Bin","year":"2015","unstructured":"Shan-Bin G, Yue T, Ling-Yan J. Long-term sustained-released in situ gels of a water-insoluble drug amphotericin B for mycotic arthritis intra-articular administration: preparation, in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2015;41:573\u201382.","journal-title":"Drug Dev Ind Pharm"},{"key":"4134_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00011-024-01890-9","volume":"73","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li M, Lu Y, Wang M, Xiao J, Xie Q, et al. Sirt1 inhibits macrophage polarization and inflammation in gouty arthritis by inhibiting the MAPK\/NF-\u03baB\/AP-1 pathway and activating the Nrf2\/HO-1 pathway. Inflamm Res. 2024;73:1173\u201384.","journal-title":"Inflamm Res"},{"issue":"3","key":"4134_CR34","doi-asserted-by":"publisher","first-page":"100913","DOI":"10.1016\/j.ajps.2024.100913","volume":"19","author":"R Wang","year":"2024","unstructured":"Wang R, Liu T, Li X, Lu E, Chen Y, Luo K, et al. Biomimetic integrated nanozyme for flare and recurrence of gouty arthritis. Asian J Pharm Sci. 2024;19:100913, 100913.","journal-title":"Asian J Pharm Sci"},{"key":"4134_CR35","doi-asserted-by":"publisher","first-page":"115875","DOI":"10.1016\/j.jep.2022.115875","volume":"302","author":"P Liu","year":"2023","unstructured":"Liu P, Xu Y, Ye J, Tan J, Hou J, Wang Y, et al. Qingre Huazhuo Jiangsuan Decoction promotes autophagy by inhibiting PI3K\/AKT\/mTOR signaling pathway to relieve acute gouty arthritis. J Ethnopharmacol. 2023;302:115875.","journal-title":"J Ethnopharmacol"},{"key":"4134_CR36","doi-asserted-by":"publisher","first-page":"114532","DOI":"10.1016\/j.biopha.2023.114532","volume":"161","author":"L Dong","year":"2023","unstructured":"Dong L, Zhang S, Chen L, Lu J, Zhao F, Long T, et al. In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour. Biomed Pharmacother. 2023;161:114532.","journal-title":"Biomed Pharmacother"},{"key":"4134_CR37","doi-asserted-by":"publisher","first-page":"32153","DOI":"10.1038\/s41598-025-16622-0","volume":"15","author":"G Ibrahim Fouad","year":"2025","unstructured":"Ibrahim Fouad G, Aly HF, Shalaby MB, Mabrouk MI, Khalil WKB, Rizk MZ. Antiarthritic activities of berberine in a rat model of gouty arthritis. Sci Rep. 2025;15:32153.","journal-title":"Sci Rep"},{"key":"4134_CR38","doi-asserted-by":"publisher","first-page":"8298615","DOI":"10.1155\/2020\/8298615","volume":"2020","author":"M Zhou","year":"2020","unstructured":"Zhou M, Ze K, Hua L, Liu L, Kuai L, Zhang M, et al. Cyr61 Promotes Inflammation of a Gouty Arthritis Model in Rats. Mediators Inflamm. 2020;2020:8298615.","journal-title":"Mediators Inflamm"},{"key":"4134_CR39","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/0192623315614119","volume":"44","author":"M Skydsgaard","year":"2016","unstructured":"Skydsgaard M. International harmonization of nomenclature and diagnostic criteria (INHAND) for lesions in the minipig. Toxicol Pathol. 2016;44:480\u20131.","journal-title":"Toxicol Pathol"},{"key":"4134_CR40","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1021\/mp500019p","volume":"11","author":"W Wu","year":"2014","unstructured":"Wu W, Chen H, Shan F, Zhou J, Sun X, Zhang L, et al. A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery. Mol Pharm. 2014;11:3378\u201385.","journal-title":"Mol Pharm"},{"key":"4134_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2013.12.020","volume":"176","author":"RRS Thakur","year":"2014","unstructured":"Thakur RRS, McMillan HL, Jones DS. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release. 2014;176:8\u201323.","journal-title":"J Control Release"},{"key":"4134_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/19466315.2018.1437071","volume":"10","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yin X, Languino LR, Altieri DC. Evaluation of drug combination effect using a Bliss independence dose-response surface model. Stat Biopharm Res. 2018;10:112\u201322.","journal-title":"Stat Biopharm Res"},{"key":"4134_CR43","doi-asserted-by":"publisher","first-page":"e0224137","DOI":"10.1371\/journal.pone.0224137","volume":"14","author":"E Demidenko","year":"2019","unstructured":"Demidenko E, Miller TW. Statistical determination of synergy based on Bliss definition of drugs independence. PLoS ONE. 2019;14:e0224137.","journal-title":"PLoS ONE"},{"key":"4134_CR44","doi-asserted-by":"crossref","unstructured":"Zhang Z, Xu J, Liu Y, Wang T, Pei J, Cheng L, et al. Mouse macrophage specific knockout of SIRT1 influences macrophage polarization and promotes angiotensin II-induced abdominal aortic aneurysm formation. J Genet Genomics. 2018;45:25\u201332.","DOI":"10.1016\/j.jgg.2018.01.002"},{"key":"4134_CR45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00210-016-1263-1","volume":"389","author":"MH Hassan","year":"2016","unstructured":"Hassan MH, Ghobara MM. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:971\u201383.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4134_CR46","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ejpb.2010.04.004","volume":"75","author":"AR Ahmed","year":"2010","unstructured":"Ahmed AR, Dashevsky A, Bodmeier R. Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems. Eur J Pharm Biopharm. 2010;75:375\u201380.","journal-title":"Eur J Pharm Biopharm"},{"key":"4134_CR47","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejpb.2019.06.007","volume":"142","author":"M Breitsamer","year":"2019","unstructured":"Breitsamer M, Stulz A, Heerklotz HH, Winter G. Do interactions between protein and phospholipids influence the release behavior from lipid-based exenatide depot systems? Eur J Pharm Biopharm. 2019;142:61\u20139.","journal-title":"Eur J Pharm Biopharm"},{"key":"4134_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/annrheumdis-2013-203670","volume":"74","author":"CS Bonnet","year":"2015","unstructured":"Bonnet CS, Williams AS, Gilbert SJ, Harvey AK, Evans BA, Mason DJ. AMPA\/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann Rheum Dis. 2015;74:242\u201351.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"4134_CR49","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/biom14080978","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S, Li D, Fan M, Yuan J, Xie C, Yuan H, et al. Mechanism of reactive oxygen species-guided immune responses in gouty arthritis and potential therapeutic targets. Biomolecules. 2024;14:978, 978.","journal-title":"Biomolecules"},{"key":"4134_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuint.2017.08.001","volume":"112","author":"A Yadav","year":"2018","unstructured":"Yadav A, Sunkaria A, Singhal N, Sandhir R. Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2\/HO-1 pathway. Neurochem Int. 2018;112:239\u201354.","journal-title":"Neurochem Int"},{"key":"4134_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/fcp.12754","volume":"36","author":"HF Miranda","year":"2022","unstructured":"Miranda HF, Noriega V, Sierralta F, Sotomayor-Z\u00e1rate R, Prieto JC. Risperidone in analgesia induced by paracetamol and meloxicam in experimental pain. Fundam Clin Pharmacol. 2022;36:494\u2013500.","journal-title":"Fundam Clin Pharmacol"},{"key":"4134_CR52","doi-asserted-by":"publisher","first-page":"100573","DOI":"10.1016\/j.mtbio.2023.100573","volume":"19","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Zhou Y, Ding R, Zou L, Zhang H, Wei X, et al. Intra-articular treatment of temporomandibular joint osteoarthritis by injecting actively-loaded meloxicam liposomes with dual-functions of anti-inflammation and lubrication. Mater Today Bio. 2023;19:100573.","journal-title":"Mater Today Bio"},{"key":"4134_CR53","doi-asserted-by":"publisher","first-page":"9932218","DOI":"10.1155\/2021\/9932218","volume":"2021","author":"D-D Zhou","year":"2021","unstructured":"Zhou D-D, Luo M, Huang S-Y, Saimaiti A, Shang A, Gan R-Y, et al. Effects and mechanisms of resveratrol on aging and age-related diseases. Oxid Med Cell Longev. 2021;2021:9932218.","journal-title":"Oxid Med Cell Longev"},{"key":"4134_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12906-018-2278-6","volume":"18","author":"H-T Hsu","year":"2018","unstructured":"Hsu H-T, Tseng Y-T, Wong W-J, Liu C-M, Lo Y-C. Resveratrol prevents nanoparticles-induced inflammation and oxidative stress via downregulation of PKC-\u03b1 and NADPH oxidase in lung epithelial A549 cells. BMC Complement Altern Med. 2018;18:211.","journal-title":"BMC Complement Altern Med"},{"key":"4134_CR55","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1159\/000487735","volume":"45","author":"J Li","year":"2018","unstructured":"Li J, Li L, Wang S, Zhang C, Zheng L, Jia Y, et al. Resveratrol alleviates inflammatory responses and oxidative stress in rat kidney ischemia-reperfusion injury and H2O2-Induced NRK-52E Cells via the Nrf2\/TLR4\/NF-\u03baB Pathway. Cell Physiol Biochem. 2018;45:1677\u201389.","journal-title":"Cell Physiol Biochem"},{"key":"4134_CR56","doi-asserted-by":"publisher","first-page":"109822","DOI":"10.1016\/j.intimp.2023.109822","volume":"116","author":"L Cui","year":"2023","unstructured":"Cui L, Guo J, Wang Z, Zhang J, Li W, Dong J, et al. Meloxicam inhibited oxidative stress and inflammatory response of LPS-stimulated bovine endometrial epithelial cells through Nrf2 and NF-\u03baB pathways. Int Immunopharmacol. 2023;116:109822.","journal-title":"Int Immunopharmacol"},{"key":"4134_CR57","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.carbpol.2018.11.050","volume":"206","author":"K-Y Lu","year":"2019","unstructured":"Lu K-Y, Lin Y-C, Lu H-T, Ho Y-C, Weng S-C, Tsai M-L, et al. A novel injectable in situ forming gel based on carboxymethyl hexanoyl chitosan\/hyaluronic acid polymer blending for sustained release of berberine. Carbohydr Polym. 2019;206:664\u201373.","journal-title":"Carbohydr Polym"},{"key":"4134_CR58","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1166\/jbn.2015.2061","volume":"11","author":"D Dyondi","year":"2015","unstructured":"Dyondi D, Sarkar A, Banerjee R. Joint surface-active phospholipid-mimetic liposomes for intra-articular delivery of paclitaxel. J Biomed Nanotechnol. 2015;11:1225\u201335.","journal-title":"J Biomed Nanotechnol"},{"key":"4134_CR59","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jare.2020.02.014","volume":"24","author":"Y-Y Lin","year":"2020","unstructured":"Lin Y-Y, Jean Y-H, Lin S-C, Feng C-W, Kuo H-M, Lai Y-C, et al. Etoricoxib prevents progression of osteolysis in repeated intra-articular monosodium urate-induced gouty arthritis in rats. J Adv Res. 2020;24:109\u201320.","journal-title":"J Adv Res"},{"key":"4134_CR60","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/j.pain.0000000000001137","volume":"159","author":"A Marcotti","year":"2018","unstructured":"Marcotti A, Miralles A, Dominguez E, Pascual E, Gomis A, Belmonte C, et al. Joint nociceptor nerve activity and pain in an animal model of acute gout and its modulation by intra-articular hyaluronan. Pain. 2018;159:739\u201348.","journal-title":"Pain"},{"issue":"5","key":"4134_CR61","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/ph18050762","volume":"18","author":"YI Asiri","year":"2025","unstructured":"Asiri YI, Pichaivel M, Parameshwaran SP, Venkatesan K, Alqahtani S, Alqahtani T, et al. Targeting hyperuricemia and NLRP3 inflammasome in gouty arthritis: a preclinical evaluation of allopurinol and disulfiram combination therapy. Pharmaceuticals (Basel). 2025;18:762, 762.","journal-title":"Pharmaceuticals (Basel)"},{"key":"4134_CR62","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2217\/nnm-2018-0221","volume":"14","author":"A Sarkar","year":"2019","unstructured":"Sarkar A, Carvalho E, D\u2019souza AA, Banerjee R. Liposome-encapsulated fish oil protein-tagged gold nanoparticles for intra-articular therapy in osteoarthritis. Nanomedicine (Lond). 2019;14:871\u201387.","journal-title":"Nanomedicine (Lond)"},{"key":"4134_CR63","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.actbio.2025.07.057","volume":"203","author":"M Wu","year":"2025","unstructured":"Wu M, Chen Z, Song B, Wang X, Liang W. Current status and future perspectives of research on intra-articular drug delivery systems for osteoarthritis therapy. Acta Biomater. 2025;203:59\u201377.","journal-title":"Acta Biomater"},{"key":"4134_CR64","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1016\/j.biomaterials.2014.05.064","volume":"35","author":"A Petit","year":"2014","unstructured":"Petit A, Sandker M, M\u00fcller B, Meyboom R, van Midwoud P, Bruin P, et al. Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels. Biomaterials. 2014;35:7919\u201328.","journal-title":"Biomaterials"},{"key":"4134_CR65","doi-asserted-by":"crossref","unstructured":"Ren T, Cong L, Wang Y, Tang Y, Tian B, Lin X, et al. Lipid emulsions in parenteral nutrition: current applications and future developments. Expert Opin Drug Deliv. 2013;10:1533\u201349.","DOI":"10.1517\/17425247.2013.824874"},{"key":"4134_CR66","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1358\/dot.2012.48.7.1813475","volume":"48","author":"RL George","year":"2012","unstructured":"George RL, Sundy JS. Pegloticase for treating refractory chronic gout. Drugs Today (Barc). 2012;48:441\u20139.","journal-title":"Drugs Today (Barc)"},{"key":"4134_CR67","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/1061186X.2023.2220083","volume":"31","author":"Z Xie","year":"2023","unstructured":"Xie Z, Wang L, Chen J, Zheng Z, Srinual S, Guo A, et al. Reduction of systemic exposure and side effects by intra-articular injection of anti-inflammatory agents for osteoarthritis: what is the safer strategy? J Drug Target. 2023;31:596\u2013611.","journal-title":"J Drug Target"},{"key":"4134_CR68","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejpb.2022.02.014","volume":"173","author":"AD Lam","year":"2022","unstructured":"Lam AD, Cao E, Leong N, Gracia G, Porter CJH, Feeney OM, et al. Intra-articular injection of biologic anti-rheumatic drugs enhances local exposure to the joint-draining lymphatics. Eur J Pharm Biopharm. 2022;173:34\u201344.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04134-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:02:26Z","timestamp":1790010146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04134-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4134"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04134-z","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}